Movement Disorders

Follow the links below to find information about movement disorders, such as ataxia and dystonia.

Updated January 2008

Printer friendly page

Related HealthInsite Topics
Parkinson's Disease
HealthInsite Topic Page
Links to information on Parkinson´s Disease.
Restless Legs Syndrome
HealthInsite Topic Page
Links to information about Restless Legs (or Leg) Syndrome.
23 Resources Found
Results 1 to 20 displayed.
1    2   
Title:   Interventions for motor apraxia following stroke
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   People with motor apraxia after stroke often have difficulty carrying out everyday activities such as making a hot drink. Some people cannot select the right object at the right time or have difficulty using objects (such as a spoon) correctly. Apraxia ...
Date:   Sep 2007
Title:   Rett syndrome
Publisher:   Better Health Channel
Description:   Rett syndrome is a severe disorder of the nervous system. It is usually only seen in girls and affects all body movement. It causes loss of speech and hand use. Girls with Rett syndrome need therapy to help them with movement and communication.
Date:   Jun 2007
Title:   Early developmental intervention programs post hospital discharge to prevent motor and cognitive impairments in preterm infants
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Preterm infants (babies born before 37 weeks) are at risk of development problems, including problems with cognitive and motor development. Cognitive development refers to thinking and learning ability and motor development refers to the way infants mov...
Date:   Dec 2006
Title:   Molindone for schizophrenia and severe mental illness
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Molindone is an older antipsychotic drug with a receptor binding profile similar to that of quetiapine, a novel atypical antipsychotic. We sought to determine the effects of molindone compared with placebo, typical and atypical antipsychotics for treati...
Title:   Treatment for ataxia in multiple sclerosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   MS is a chronic disease of the central nervous system which typically affects both young and middle aged adults. It can result in many different symptoms including ataxia....
Date:   Aug 2006
Title:   Haloperidol versus placebo for schizophrenia
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Schizophrenia is a serious, disabling mental illness that can affect sufferers for most of their adult life; drug treatments are central to the care of people with schizophrenia. In the 1950's the introduction of chlorpromazine and haloperidol, two typi...
Date:   Aug 2006
Title:   Anticholinergics for neuroleptic-induced acute akathisia
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Akathisia is a common and distressing adverse effect of antipsychotic drugs and is characterised by restlessness and mental unease, both of which can be intense. Akathisia is associated with patterns of restless movement, including rocking, walking on t...
Date:   Aug 2006
Title:   Congenital torticollis
Publisher:   Child and Youth Health - CYH (South Australia)
Description:   About 1 in 200 babies have torticollis, a shortening of a muscle in the neck causing their head to tilt to one side. The muscle affected is called the sterno-cleido-mastoid muscle (SCM),
Date:   Jan 2006
Title:   Non-neuroleptic catecholaminergic drugs for neuroleptic-induced tardive dyskinesia
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Tardive dyskinesia is a disfiguring and disabling movement disorder which is often caused by drugs used to treat schizophrenia. Several of the Cochrane reviews have summarised the effects of the many treatments used to manage these involuntary movements...
Date:   Oct 2005
Title:   Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis...
Date:   Aug 2005
Title:   Schizophrenia medicines
Publisher:   myDr
Description:   Medicines for schizophrenia can be broadly classified into 'older' and 'newer' antipsychotics.
Date:   May 2005
Title:   Benperidol for schizophrenia
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Benperidol is a relatively old drug that is used for the treatment of schizophrenia in several European countries. We identified only one small, poorly reported, unpublished, randomised trial comparing benperidol with another antipsychotic. Unfortunatel...
Date:   Feb 2005
Title:   Antipsychotic medications
Publisher:   myDr
Description:   Psychotic illnesses such as schizophrenia are associated with changes in brain chemistry.
Date:   Jan 2005
Title:   Botulinum toxin type A therapy for cervical dystonia
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Cervical dystonia is characterized by involuntary posturing of the head and frequently is associated with neck pain. Disability and social withdrawal are common. A single injection cycle of BtA is effective and safe for treating cervical dystonia and fu...
Date:   Oct 2004
Title:   Botulinum toxin type A versus anticholinergics for cervical dystonia
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Cervical dystonia is characterized by involuntary posturing of the head and frequently is associated with neck pain. Disability and social withdrawal are common. Botulinum toxin Type A (BtA) is now the first line therapy but previously anticholinergics ...
Date:   Oct 2004
Title:   Central action beta-blockers versus placebo for neuroleptic-induced acute akathisia
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Akathisia is recognised as one of the most common and distressing of the early-onset adverse effects of neuroleptic drugs. This movement disorder is characterised by a subjective report of inner restlessness, mental unease or dysphoria, which can be int...
Date:   Aug 2004
Title:   Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   BtA causes weakness when injected into muscles to increase movement and function in treated limbs. In the absence of significant side effects and with only some supporting evidence, there is a need for further research to explore its use as an adjunct t...
Date:   Jul 2004
Title:   Botulinum toxin type B for cervical dystonia
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Cervical dystonia is the most common form of focal dystonia and is characterized by involuntary posturing of the head. It is frequently associated with neck pain and may lead to physical disability and social withdrawal. Botulinum toxin type A (BtA) has...
Date:   Jun 2004
Title:   Botulinum toxin type A versus botulinum toxin type B for cervical dystonia
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Cervical dystonia is the most common form of focal dystonia and is characterized by involuntary posturing of the head. It is frequently associated with neck pain and may lead to physical disability and social withdrawal. Botulinum toxin type A (BtA) has...
Date:   May 2003
Title:   Amisulpride for schizophrenia
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Amisulpride is a new antipsychotic compound. This review suggests that it is more effective than a placebo for the treatment of schizophrenia. Amisulpride also has some advantages for the treatment of the general and negative symptoms of schizophrenia, ...
Date:   Jan 2002
Results 1 to 20 displayed.
1    2